ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

DRCCA Board Again Approves Breast Cancer Dietary Study

May 13, 1983

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009

The Cancer Letter Provides Full Text Of Publications To University Of Kentucky.

October 19, 2001

Yarbro Refuses To Seek Core Renewal, Quits Director Post

September 22, 1978

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

August 12, 2011